Heart surgery drug cuts dangerous lung complications
NCT ID NCT07237243
Summary
This study looked at whether a drug called ulinastatin, given during heart surgery, can reduce serious lung problems that sometimes happen after the operation. Researchers analyzed data from over 4,500 patients who had heart surgery and also studied how the drug might work in the body. They found that patients who received the drug had a lower rate of these lung complications.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARDIAC SURGERY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Wuhan, Hubei, 430030, China
Conditions
Explore the condition pages connected to this study.